SCHEMBL13015667

SCHEMBL13015667

COc1ccc2cc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 5/20 0.58
CYP11B1 P15538 4/20 0.58
CYP1A2 P05177 4/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C9 P11712 3/20 0.54
CYP2C19 P33261 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2B6 P20813 1/20 0.54
HSD17B1 P14061 1/20 0.53
HSD17B2 P37059 1/20 0.53
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
CYP17A1 P05093 2/20 0.51
CYP19A1 P11511 1/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27872144 0.97 CYP1A2 (0.56) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL1041430 0.95 CYP1A2 (0.61) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL14233923 0.93 CYP1A2 (0.59) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL12331009 0.88 CYP11B2 (0.57) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL22993026 0.88 CYP1A2 (0.57) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL13820546 0.87 CYP11B2 (0.57) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL10030011 0.87 CYP1A2 (0.52) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL5551808 0.87 CYP1A2 (0.52) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL11978895 0.87 CYP11B2 (0.49) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9
SCHEMBL27862687 0.86 CYP1A2 (0.60) CYP11B2CYP11B1CYP1A2CYP2A6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 US disclosed
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 US disclosed
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 US disclosed
WO-2015141608-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME JNC株式会社 2015-09-24 WO disclosed
CN-103189355-A Electron transport material and organic electroluminescent device using the same JNC CORP 2013-07-03 CN disclosed
CN-102414179-A Electron transport material and organic electroluminescent element using same JNC CORP 2012-04-11 CN disclosed
WO-2010137678-A1 ELECTRON TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME チッソ株式会社 (JP) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC26A3, SLC9A1, HVCN1 CYP11B2 823/4885CYP11B1 749/4885CYP1A2 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.